Intracranial Arterial Stenosis in Young Patients — ICAS-Young

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Intracranial Arterial Stenosis Clinical Trial

Official title:
Intracranial Arterial Stenosis in Young Patients: a Multicenter Longitudinal Cohort Study

Status Recruiting

Clinical Trial Summary

The goal of this study is to evaluate the characteristic of intracranial arterial stenosis among young patients.

n/a

NCT number	NCT05844176
Study type	Observational [Patient Registry]
Source	Capital Medical University
Contact	Xunming Ji, MD
Phone	010-83199439
Email	jixm@ccmu.edu.cn
Status	Recruiting
Phase
Start date	June 1, 2022
Completion date	October 1, 2024

See also
Status	Clinical Trial	Phase
Completed	`NCT01819597` - Surgical Indirect Revascularization For Symptomatic Intracranial Arterial Stenosis	N/A
Enrolling by invitation	`NCT04240119` - Angiogenic Markers in Cerebrovascular Disease (ANFIS)
Recruiting	`NCT01553643` - A Randomized Double Blind Placebo Control Study of Huang-Chi-Wu-Wu- Tang in Patients With Intracranial Arterial Stenosis	Phase 4
Completed	`NCT01570231` - Feasibility, Safety and Efficacy of Remote Ischemic Preconditioning for Symptomatic Intracranial Arterial Stenosis in Octogenarians	Phase 1
Completed	`NCT02041117` - Resuvastatin Treatment for Symptomatic Middle Cerebral Artery Stenosis Based on High-resolution Magnetic Resonance Imaging	Phase 4